To a lesser extent, ATRA can also induce differentiation in non-APL cells, in particular in AML with IDH1/IDH2 mutations [36] or induce cell death in NPM1mut AML when used in combination with Arsenic trioxide [37], [38]. This evidence concerns the gene IDH1 and acute myeloid leukemia.